The fentanyl supply keeps changing, and one of the newer drugs raising concern is medetomidine, sometimes called “rhino tranq” or “dex.” It is a powerful veterinary sedative that is not approved for human use, but it has been detected in the illegal fentanyl supply in several parts of the United States. The CDC issued a 2026 health advisory warning that medetomidine is increasingly being found in illegally made fentanyl and other unregulated drugs.
For people using fentanyl, this makes an already dangerous drug supply even harder to predict. Medetomidine is not an opioid, so it does not respond to naloxone the same way fentanyl does. However, because fentanyl is usually still involved, naloxone should still be given during a suspected overdose. The concern is that someone may receive naloxone, begin breathing better, but still remain deeply sedated or medically unstable because of the non-opioid sedative mixed into the drug supply.
Medetomidine withdrawal is also becoming a major concern. Some people exposed to medetomidine-contaminated fentanyl have developed severe withdrawal symptoms that look different from typical opioid withdrawal and may require hospital-level care.
What Is Medetomidine?
Medetomidine is a sedative used in veterinary medicine. It belongs to a class of drugs called alpha-2 adrenergic agonists, which means it affects the nervous system in ways that can slow certain body functions. Drugs in this category can reduce sympathetic nervous system activity, which may lower heart rate, blood pressure, alertness, and breathing drive.
In the illegal drug supply, medetomidine is concerning because people usually do not know they are taking it. They may think they are using fentanyl, heroin, or another opioid, but the substance may also contain medetomidine, xylazine, benzodiazepines, nitazenes, or other dangerous additives.
This is part of a larger pattern. Fentanyl is no longer just fentanyl in many areas. It is often mixed with other substances that can change how an overdose looks, how withdrawal feels, and what kind of treatment is needed. The DEA warned in May 2026 that fentanyl is increasingly being mixed with emerging synthetic and sedating drugs, including xylazine and medetomidine.
The drug works by suppressing activity within the central nervous system, producing:
- Deep sedation
- Drowsiness
- Slowed heart rate
- Lower blood pressure
- Reduced respiratory drive
- Decreased awareness and responsiveness
Drug checking programs first identified medetomidine in the illicit opioid supply in North America around 2022. Since then, detections have rapidly increased across multiple states.
Why Is It Called “Rhino Tranq”?
The nickname “rhino tranq” is street language. It can be misleading because medetomidine is not simply a stronger version of xylazine, and not every sedative in the drug supply is the same. Some people also use names like “dex” because medetomidine is chemically related to dexmedetomidine, a medication used in medical settings under controlled conditions.
The important point is not the nickname. The important point is that medetomidine is a potent non-opioid sedative that can complicate overdose response and withdrawal care.
Medetomidine vs. Xylazine
Xylazine, often called “tranq,” became well known because it was showing up in fentanyl and causing serious wounds, sedation, and complicated withdrawal. Medetomidine is different, but it creates some similar concerns.
| Drug | What It Is | Approved for Humans? | Common Concern in Fentanyl Supply |
|---|---|---|---|
| Fentanyl | Synthetic opioid | Yes, in medical settings | Respiratory depression, overdose, severe opioid dependence |
| Xylazine | Veterinary sedative | No | Sedation, wounds, overdose complications, withdrawal symptoms |
| Medetomidine | Veterinary sedative | No | Severe sedation, unstable withdrawal, high blood pressure, fast heart rate, ICU-level complications |
Medetomidine and xylazine are both alpha-2 adrenergic agonists, but medetomidine appears to create a more intense withdrawal picture in some patients. In Philadelphia, CDC investigators described hospitalizations involving fentanyl withdrawal complicated by severe autonomic symptoms, including high blood pressure and fast heart rate. Standard fentanyl and xylazine withdrawal approaches were not always enough, and some patients responded to dexmedetomidine in medical settings.
Why Are Drug Dealers Adding Medetomidine to Fentanyl?
Experts believe medetomidine is being added to fentanyl for several reasons:
| Possible Reason | Impact |
|---|---|
| Extends sedation | Makes fentanyl feel stronger or longer lasting |
| Increases perceived potency | Creates a heavier “nod” effect |
| Lowers manufacturing costs | Allows dilution of opioid content |
| Replaces xylazine in some markets | Produces similar sedative effects |
| Increases addiction potential | Creates additional physical dependence |
As law enforcement and public health agencies have increased surveillance of xylazine, some regions have seen medetomidine begin replacing or supplementing traditional tranq mixtures.
How Common Is Medetomidine in Street Drugs?
The prevalence of medetomidine varies by region, but public health agencies have documented a rapid increase in detections.
Recent surveillance has found:
| Finding | Result |
| Philadelphia opioid samples (Q4 2024) | 72% positive for medetomidine |
| New York opioid samples (2025) | 37% positive |
| Chicago overdose cluster | All confirmed cases involved fentanyl plus medetomidine |
| Wastewater surveillance (2025-2026) | Detected in at least 14 states |
| CDC findings | Increasingly detected in fentanyl nationwide |
Federal agencies have now issued nationwide warnings regarding the drug’s expansion throughout the illicit opioid market.
What Does a Medetomidine Overdose Look Like?
Because medetomidine is usually mixed with fentanyl, overdose symptoms often involve both substances.
Common symptoms include:
- Extreme sedation
- Unresponsiveness
- Slow breathing
- Slow heart rate (bradycardia)
- Low blood pressure
- Blue lips or fingertips
- Loss of consciousness
- Coma
One of the biggest challenges is that naloxone only reverses the opioid portion of the overdose.
Even after naloxone is administered, a person may remain heavily sedated because medetomidine is still active in their system. This can make overdose response more confusing for families and first responders.
Can Narcan Reverse Medetomidine?
Naloxone reverses opioid effects. It can help restore breathing when fentanyl or another opioid is involved. Medetomidine is not an opioid, so naloxone does not directly reverse medetomidine sedation.
That does not mean naloxone should be withheld. Most medetomidine-related overdoses still involve fentanyl or other opioids, so naloxone should still be given during a suspected overdose. The difference is that the person may need more medical help even after naloxone is administered. They may continue to appear sedated, confused, unstable, or difficult to wake because another drug is involved.
What Is Medetomidine Withdrawal?
Medetomidine withdrawal has become one of the most concerning aspects of the drug. Healthcare providers in Philadelphia, Pittsburgh, Chicago, and other cities have reported patients experiencing severe withdrawal symptoms that do not respond well to traditional opioid withdrawal treatment alone.
Unlike fentanyl withdrawal, which is primarily opioid-related, medetomidine withdrawal affects the body’s adrenergic nervous system.
Symptoms can include:
- Severe anxiety
- Agitation
- Panic
- High blood pressure
- Rapid heart rate
- Nausea
- Vomiting
- Sweating
- Tremors
- Insomnia
- Confusion
- Altered consciousness
- Restlessness
Some patients have required intensive care due to the severity of symptoms.
Medetomidine Withdrawal vs. Fentanyl Withdrawal
| Symptom | Fentanyl Withdrawal | Medetomidine Withdrawal |
| Muscle aches | Common | Less common |
| Cravings | Severe | Moderate |
| Anxiety | Common | Severe |
| High blood pressure | Mild to moderate | Often severe |
| Rapid heart rate | Moderate | Severe |
| Agitation | Moderate | Severe |
| Treatment resistance | Usually manageable | Frequently difficult |
| ICU admissions | Rare | More common in severe cases |
Many people withdrawing from fentanyl today may actually be experiencing withdrawal from both fentanyl and medetomidine without realizing it.
Why Traditional Detox Protocols May Not Be Enough
Fentanyl withdrawal is already difficult. Because fentanyl is highly potent and can stay in body tissues, withdrawal may be intense, delayed, or unpredictable. When medetomidine is added, the body may be dealing with more than opioid withdrawal.
Opioid withdrawal treatment often focuses on medications like buprenorphine, methadone, clonidine, comfort medications, fluids, and supportive care. Those tools may still be important, but medetomidine exposure can create a different kind of withdrawal syndrome involving the autonomic nervous system. That is the system that helps regulate heart rate, blood pressure, sweating, stress response, and body temperature.
A 2025 clinical report on medetomidine-adulterated fentanyl described severe withdrawal and warned that standard withdrawal protocols may have limitations. The authors noted that clinicians may need to recognize the role of alpha-2 agonist withdrawal and adjust care accordingly.
In simple terms, someone may not just be “dope sick.” Their nervous system may be dangerously overactivated, and that can require medical monitoring.
Why Detoxing Alone Can Be Risky
Many people try to detox at home because they are afraid, ashamed, uninsured, or unsure whether treatment will actually help. With today’s drug supply, detoxing alone is becoming more dangerous.
The problem is that a person may not know what their body has become dependent on. They may believe they are withdrawing from fentanyl, but they may also be withdrawing from medetomidine, xylazine, benzodiazepines, alcohol, or other substances. Each one can change the withdrawal process.
Medetomidine withdrawal is especially concerning because it may involve unstable blood pressure, rapid heart rate, agitation, dehydration, and medical complications. These are not symptoms someone should simply try to “push through” without support.
Medical detox can help by monitoring vital signs, managing dehydration, treating nausea and anxiety, supporting sleep, and identifying when a higher level of care is needed. For people with opioid use disorder, detox can also connect them to longer-term treatment options like medication-assisted treatment, therapy, relapse prevention planning, and continuing care.
Treatment After Medetomidine and Fentanyl Exposure
Although medetomidine presents new challenges, recovery is still possible. A comprehensive treatment plan may include:
Medical Detox
Medical professionals can monitor withdrawal symptoms and adjust treatment based on a person’s specific needs.
Medication-Assisted Treatment
Medications such as buprenorphine or methadone may help address opioid dependence while clinicians manage non-opioid withdrawal symptoms separately.
Residential Treatment
Inpatient treatment provides a safe environment away from drug access while individuals stabilize physically and emotionally.
Behavioral Therapy
Evidence based therapies help address the underlying causes of addiction while developing long term relapse prevention strategies.
Ongoing Recovery Support
Long term recovery often includes outpatient treatment, support groups, counseling, alumni programs, and continued medical care.
The Future of the Fentanyl Crisis
The emergence of medetomidine highlights a troubling reality. The modern overdose crisis is no longer driven by opioids alone. Today’s illicit drug supply often contains combinations of fentanyl, xylazine, benzodiazepines, medetomidine, synthetic cannabinoids, and other substances that create entirely new medical challenges.
As public health agencies continue tracking Rhino Tranq, one message remains clear: No one can reliably know what is inside an illicit pill, powder, or bag purchased on the street. Even experienced users are increasingly exposed to substances they never intended to take.
If you or someone you love is struggling with fentanyl, heroin, counterfeit pills, or other opioids, professional treatment can help you safely navigate withdrawal and begin recovery before the next dangerous adulterant appears in the drug supply.
The Bigger Problem: People Often Do Not Know What They Took
One of the scariest parts of medetomidine is that many people exposed to it did not choose it. They may have purchased fentanyl, heroin, counterfeit pills, or another substance without knowing it contained a veterinary sedative.
This is why overdose prevention, drug checking, medical detox, and treatment access matter. People cannot make informed choices if the drug supply is constantly changing and contaminated. Public health reports have described medetomidine appearing through law enforcement seizures, drug checking, paraphernalia testing, wastewater analysis, and clinical overdose cases.
For families, this means a loved one’s substance use may be even more dangerous than it appears. For people using fentanyl, it means the same amount they used before may affect them differently today. The bag, pill, or powder may not contain what they think it contains.
Frequently Asked Questions
What is medetomidine?
Medetomidine is a powerful veterinary sedative. It is not approved for human use, but it has been found in the illegal fentanyl supply.
Is medetomidine the same as xylazine?
No. Medetomidine and xylazine are both veterinary sedatives and alpha-2 adrenergic agonists, but they are different drugs. Both can complicate overdose and withdrawal care.
Why is medetomidine called “rhino tranq”?
“Rhino tranq” is a street nickname. The name is not medically precise, but it is being used to describe medetomidine and other powerful sedatives showing up in the drug supply.
Can medetomidine cause withdrawal?
Yes. CDC reports warn that regular exposure to medetomidine may lead to severe withdrawal symptoms when a person stops using it or after naloxone is given during an overdose.
What are medetomidine withdrawal symptoms?
Symptoms may include severe anxiety, agitation, high blood pressure, fast heart rate, nausea, vomiting, sweating, confusion, and unstable vital signs.
Does naloxone reverse medetomidine?
No. Naloxone reverses opioids, not medetomidine. However, naloxone should still be given during a suspected overdose because fentanyl is often involved.
Is medetomidine withdrawal dangerous?
It can be. Severe withdrawal may require emergency care, hospital monitoring, or intensive care in some cases.
Sources
- Centers for Disease Control and Prevention. (2026, April 2). Medetomidine in the U.S. illegal fentanyl supply: CDC Health Alert Network Health Advisory. https://www.cdc.gov/han/php/notices/han00527.html
- Centers for Disease Control and Prevention. (2026, April 2). Medetomidine situation summary. https://www.cdc.gov/overdose-prevention/situation-summary/medetomidine.html
- Drug Enforcement Administration. (2026, May 12). Public safety advisory: Heightened threat: Fentanyl mixed with emerging synthetic drugs. https://www.dea.gov/press-releases/2026/05/12/public-safety-advisory
- Huo, S., et al. (2025). Notes from the field: Suspected medetomidine withdrawal among patients hospitalized for fentanyl withdrawal. Morbidity and Mortality Weekly Report. https://www.cdc.gov/mmwr/volumes/74/wr/mm7415a2.htm
- London, K. S., et al. (2025). Severe fentanyl withdrawal associated with medetomidine-adulterated fentanyl exposure. PubMed. https://pubmed.ncbi.nlm.nih.gov/40747932/
- Reuters. (2026, April 2). U.S. health officials warn of veterinary sedative in illegal drug supply. https://www.reuters.com/business/healthcare-pharmaceuticals/us-health-officials-warn-veterinary-sedative-illegal-drug-supply-2026-04-02/
- Sibley, A. L., et al. (2025). Emergence of medetomidine in the unregulated drug supply. https://pmc.ncbi.nlm.nih.gov/articles/PMC12581931/
- Zhu, D. T., et al. (2025). Responding to medetomidine: Clinical and public health needs. The Lancet Regional Health, Americas, 44, 101053. https://www.sciencedirect.com/science/article/pii/S2667193X25000638
